retatrutide gip glp-1 glucagon receptor agonist Retatrutide: How the Triple Compares to Tirzepatide Structural insights into the triple

Why this trial matters: First triple hormone receptor agonist showing major Phase III weight-loss efficacy Delivers weight-loss outcomes far beyond many current therapies Suggests a potential new metabolic and obesity care benchmark Semaglutide Shows Consistent Liver Benefits in MASH In the Phase III ESSENCE study, once-weekly semaglutide 2.4 mg significantly increased rates of steatohepatitis resolution and fibrosis improvement on liver biopsy in adults with metabolic dysfunction-associated steatohepatitis (MASH), compared with placebo

Immunity 39 , 899911 (2013)

This is particularly useful if you suspect your thyroid issues are autoimmune-related (Hashimotos), which can significantly impact how you feel even if your TSH is "normal." Gold: The Health Snapshot The Thyroid Premium Gold tier is often our most popular choice for those struggling with fatigue and weight

Topline data in the Phase III ORIGIN trial is expected in H2 2026

Steroids may also contribute to a leaner appearance by helping maintain muscle mass during calorie restriction

So you regain the weight